ADRB2 Arg16Gly is associated with nocturnal asthma symptoms despite LABA use in two European pediatric asthma studies
S. Vijverberg (Utrecht, Netherlands)
Source: International Congress 2022 – Science slam
Session: Science slam
Session type: Science slam
Number: 0
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Vijverberg (Utrecht, Netherlands). ADRB2 Arg16Gly is associated with nocturnal asthma symptoms despite LABA use in two European pediatric asthma studies. International Congress 2022 – Science slam
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|